AXIM BIOTECHNOLOGI COM USD0.0001 (AXIM)

7.96
OTC Markets
Prev Close 8.95
Day Low/High 7.50 / 9.09
52 Wk Low/High 0.21 / 10.00
Exchange OTC Markets
Shares Outstanding 51.49B
Market Cap 460.86M
Div & Yield N.A. (N.A)

Latest News

New U.S. Patent Allowance Granted To AXIM® Biotech For Use Of All Cannabinoids In Its Controlled-Release Chewing Gum Products

New U.S. Patent Allowance Granted To AXIM® Biotech For Use Of All Cannabinoids In Its Controlled-Release Chewing Gum Products

Allows Award-Winning Cannabinoid Release Chewing Gum Products to be Used as Delivery Mechanism for All Cannabinoids, Including THC, CBD, CBG, etc.

AXIM® Biotechnologies, Inc. Publishes Product Pipeline Chart For Pharmaceutical Clinical Trials Program In Cannabinoid R&D

AXIM® Biotechnologies, Inc. Publishes Product Pipeline Chart For Pharmaceutical Clinical Trials Program In Cannabinoid R&D

Cannabinoid Innovator's Product Pipeline Highlights Timelines of Its Intellectual Property (IP) Protected Cannabinoid-Based Products from Pre-Clinical to NDA for Multiple Indications

AXIM® Biotechnologies, Inc. Secures Funding To Continue Pharmaceutical Clinical Trials Program In Cannabinoid Research And Development For Multiple Indications

AXIM® Biotechnologies, Inc. Secures Funding To Continue Pharmaceutical Clinical Trials Program In Cannabinoid Research And Development For Multiple Indications

Financing Enables Cannabinoid Innovator to Continue Phase I-II Trials Of Numerous Intellectual Property (IP) Protected Cannabinoid-Based Products

AXIM Biotechnologies, Inc. CEO To Speak At First-Ever National Symposium On Medical Cannabis For Healthcare Professionals In Mexico City

AXIM Biotechnologies, Inc. CEO To Speak At First-Ever National Symposium On Medical Cannabis For Healthcare Professionals In Mexico City

AXIM CEO to Discuss Company's Use of Cannabinoids to Treat Health Conditions with No Known Cure at Symposium Held by Medical Marijuana, Inc.'s HempMeds® Mexico

AXIM Biotechnologies, Inc. Increases CanChew Cannabidiol (CBD) Gum Donations By 200%, Beneficiaries Include U.S. Veterans And Legacy Customers

AXIM Biotechnologies, Inc. Increases CanChew Cannabidiol (CBD) Gum Donations By 200%, Beneficiaries Include U.S. Veterans And Legacy Customers

AXIM® Launches Appreciation Program That Benefits U.S. Warfighters, Emphasizes Freedom to Choose Hemp Based Health and Wellness Options, Rewards Long-Term Consumer Use

AXIM Biotech Begins Human Clinical Trials With Cannabigerol (CBG) For Psoriasis And Eczema In Patients

AXIM Biotech Begins Human Clinical Trials With Cannabigerol (CBG) For Psoriasis And Eczema In Patients

AXIM's CBG Clinical Trials Led by World-Renowned Dermatologist and Specialist on Psoriasis and Eczema, Dr. Meinardi, at The Maurits Clinics in The Hague, The Netherlands

AXIM Biotech CEO Appointed To American Pain Association Board Of Advisors, Addresses American Opioid Abuse Epidemic

AXIM Biotech CEO Appointed To American Pain Association Board Of Advisors, Addresses American Opioid Abuse Epidemic

AXIM CEO Joins APA Board of Advisors in Appeal to U.S. Surgeon General About the No. 1 U.S. Health Crisis: Prescription Opioid Abuse Epidemic

AXIM Biotech Leads Cannabis Industry In Cannabinoid Research, Development And Intellectual Property; Tackles 15 Debilitating Conditions With No Known Cure

AXIM Biotech Leads Cannabis Industry In Cannabinoid Research, Development And Intellectual Property; Tackles 15 Debilitating Conditions With No Known Cure

Global Hemp Innovator Unveils Impressive Pipeline of Cannabis-Based Health and Wellness Solutions

AXIM Biotechnologies Expands Executive Team And Advisory Board With Finance And Pro Sports Leaders: Seth Yakatan And Marvin Washington

AXIM Biotechnologies Expands Executive Team And Advisory Board With Finance And Pro Sports Leaders: Seth Yakatan And Marvin Washington

Hemp Industry Innovator, AXIM(R) Biotech, Adds Two Industry Leaders to the Company's Advisory Board: Seth Yakatan - Biotech Finance Consultant; and Marvin Washington - NFL Star and Sports Advisor

AXIM Biotechnologies Secures Land Down Payment For Hemp Life Sciences Manufacturing Site

AXIM Biotechnologies Secures Land Down Payment For Hemp Life Sciences Manufacturing Site

Company's Global Manufacturing Facility Move Forward in Almere, The Netherlands

Photo Release -- AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace To Advisory Board

Photo Release -- AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace To Advisory Board

Veteran Marketing Executive Who Grew WebMD's Audience to 25 Million Unique Monthly Visitors Brings Decades of Health Industry Experience to AXIM Biotech's Board of Advisors

AXIM Biotech Explains Cannabis Chewing Gum Clinical Trials For Pain And Spasticity With MS, Plans To Enter General Pain Market

AXIM Biotech Explains Cannabis Chewing Gum Clinical Trials For Pain And Spasticity With MS, Plans To Enter General Pain Market

Agricultural Hemp Biotech's Cannabinoid Innovations for Multiple Sclerosis Patients Lead to Entry Into $60 Billion General Pain Market

AXIM Biotech Announces Launch Of Clinical Trials On MedChew RX(TM) And Development Of Pharmaceutical-Grade Cannabis Chewing Gum

AXIM Biotech Announces Launch Of Clinical Trials On MedChew RX(TM) And Development Of Pharmaceutical-Grade Cannabis Chewing Gum

Global Industrial Hemp Bioscience Company Announces Clinical Trials at Free University of Amsterdam, The Netherlands

AXIM Biotech Presents Patented Cannabinoid Delivery Methods At My Compassion's Chicago Cannabis Conference

AXIM Biotech Presents Patented Cannabinoid Delivery Methods At My Compassion's Chicago Cannabis Conference

Global Hemp Biotech Company Fosters Cannabinoid Education With Patients, Peers and the Public

Photo Release -- AXIM Biotechnologies, Inc. Supports Adopt-A-Soldier Platoon's Warfighter Independence Weekend

Photo Release -- AXIM Biotechnologies, Inc. Supports Adopt-A-Soldier Platoon's Warfighter Independence Weekend

Award-Winning Patented Cannabinoid Release Gum, CanChew(R), Donated in Support of U.S. Service Members at July 4th Weekend Event

Photo Release -- AXIM Biotech CEO Addresses Cannabinoid Delivery Innovations At My Compassion's Cannabis Conference Chicago

Photo Release -- AXIM Biotech CEO Addresses Cannabinoid Delivery Innovations At My Compassion's Cannabis Conference Chicago

Renowned Doctors Educate Patients, Peers and Public at Largest Midwest Cannabis Health Education Conference July 23-25 at Chicago's Navy Pier

Photo Release -- AXIM Biotech Announces Hemp Innovations For Life Sciences

Photo Release -- AXIM Biotech Announces Hemp Innovations For Life Sciences

Global Industrial Hemp Bioscience Company Announces Entry Into Food and Pharmaceutical Markets

Photo Release -- AXIM Biotech CEO Honored By Adopt-A-Soldier Platoon

Photo Release -- AXIM Biotech CEO Honored By Adopt-A-Soldier Platoon

Industrial Hemp Biosciences Leader Recognized for Service Through Generous Donations of Award-Winning Hemp-Infused Chewing Gum Donation to U.S. Service Members

Photo Release -- AXIM Biotech's New Website Commissioned To Award Winning Artist Andre Weinfeld

Photo Release -- AXIM Biotech's New Website Commissioned To Award Winning Artist Andre Weinfeld

Industrial Hemp Biotech's Mission Conveyed Through the Eyes of Renowned Director and Artist

Photo Release -- AXIM Biotech Secures Exclusive License Agreement To Patented Cannabidiol (CBD) Gum

Photo Release -- AXIM Biotech Secures Exclusive License Agreement To Patented Cannabidiol (CBD) Gum

CBD Hemp Oil Chewing Gum Provides Discrete Option for Hemp Consumers Worldwide

Photo Release -- AXIM Biotech Garners Global Headlines After Announcing First-Ever Lines Of Cannabigerol (CBG) Products

Photo Release -- AXIM Biotech Garners Global Headlines After Announcing First-Ever Lines Of Cannabigerol (CBG) Products

Industrial Hemp Biotech Company Develops Everyday-Use Cannabigerol (CBG) Products

Photo Release -- Dr. Jacques F. Meis, World-Renowned Infectious Disease Specialist, Joins AXIM Biotechnologies, Inc.'s Advisory Board

Photo Release -- Dr. Jacques F. Meis, World-Renowned Infectious Disease Specialist, Joins AXIM Biotechnologies, Inc.'s Advisory Board

Global Industrial Hemp Biosciences Leader Furthers Mission of Addressing Infectious Diseases Through Advances in Cannabinoid-Based Product Development

Photo Release -- AXIM Biotech Unveils World's First Hemp Cannabigerol (CBG) Oral Care & Cosmetic Products

Photo Release -- AXIM Biotech Unveils World's First Hemp Cannabigerol (CBG) Oral Care & Cosmetic Products

Global Hemp Biotech Company Gains Global News Coverage on New Cannabigerol (CBG)-Based Products Soon to Be Available Worldwide